Page last updated: 2024-10-31

mitotane and Bonnevie-Ullrich Syndrome

mitotane has been researched along with Bonnevie-Ullrich Syndrome in 1 studies

Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.

Bonnevie-Ullrich Syndrome: This syndrome that was originally observed by Ullrich, and designated as identical to TURNER SYNDROME, related the webbing of the neck, loose skin and other anomalies of the syndrome to accumulation of fluid in the embryo starting at the head and dispersing to the extremities (as observed by Bonnevie in mice). Commonly observed at birth in Turner Syndrome and NOONAN SYNDROME; EDEMA of the extremities usually recedes by one year and is an early sign of Turner syndrome, especially in female neonates.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Senior, B1

Other Studies

1 other study available for mitotane and Bonnevie-Ullrich Syndrome

ArticleYear
Cessation of growth.
    Hospital practice, 1978, Volume: 13, Issue:1

    Topics: Adolescent; Cushing Syndrome; Diagnosis, Differential; Growth Disorders; Humans; Mitotane; Turner Sy

1978